Indication
Metastatic Hypopharyngeal Squamous Cell Carcinoma
2 clinical trials
3 products
2 drugs
Clinical trial
A Phase II Trial of the Efficacy and Safety of the Combination of Cemiplimab and Low-Dose Paclitaxel and Carboplatin in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckStatus: Recruiting, Estimated PCD: 2024-12-31
Product
CarboplatinProduct
CemiplimabDrug
TiragolumabClinical trial
A Phase 2 Study of Ipatasertib in Combination With Pembrolizumab for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and NeckStatus: Recruiting, Estimated PCD: 2025-06-30
Product
IpatasertibDrug
mFOLFOX6